OpenAI Acquires Orchestra Bio
October 21, 2026
October 21, 2026
SAN FRANCISCO, California, Oct. 21 -- OpenAI, an Artificial Intelligence research and deployment company, issued the following news:
* * *
October 20, 2026
OpenAI acquires Orchestra Bio
AI-powered drug development platform accelerates progress toward new treatments.
-
OpenAI has acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development. We're bringing Orchestr . . .
* * *
October 20, 2026
OpenAI acquires Orchestra Bio
AI-powered drug development platform accelerates progress toward new treatments.
-
OpenAI has acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development. We're bringing Orchestr . . .